The UCSF Osher Lifelong Learning Institute (OLLI) kicks off its third year this fall with new courses for the public starting in October.

Researchers say an antibiotic used for topical applications looks promising to fight Huntington's disease in mice studies.

The California Institute for Regenerative Medicine (CIRM) has awarded the J. David Gladstone Institutes a $2.4 million grant to create a CIRM Scholars Training Program focusing on stem cell research.

Women with atrial fibrillation who are not on anticoagulant therapy have a higher rate of ischemic stroke and face a higher absolute risk for stroke than do men with the condition, according to a joint study by researchers at the UCSF ...

A team of scientists from the Gladstone Institute of Cardiovascular Disease (GICD) has identified a key factor in heart development that could help advance gene therapy for treating cardiac disorders.

Members of the Gladstone Institutes' Conklin lab and Embryonic Stem Cell Lab provided cells and helped train museum staff members for the development and launch of a current Exploratorium exhibit featuring live mouse embryonic stem cells.

Capitalizing on the strength of its research and clinical enterprise, UCSF is launching the Institute for Stem Cell and Tissue Biology, providing a framework for close collaboration among investigators from the University's Schools of Dentistry, Medicine, Nursing and Pharmacy.

A thought-provoking exhibit, titled "Generations: A Tribute to Mothers and Daughters around the World," opens Thursday, Sept. 15 at UCSF.

Two common weight loss supplements promoted as ephedra-free and safe for dieters caused increased heart rate among healthy people, and could have harmful health effects in some people, according to a study by UCSF scientists.

Clioquinol, an antibiotic that was banned for internal use in the United States in 1971 but is still used in topical applications, appears to block the genetic action of Huntington's disease in mice and in cell culture